UroGen Pharma Ltd
URGN
Market Cap$899.84M
Close$
$15.60
17% downside
Current Fair Value
17% downsideOvervalued by 17% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $899.84 Million |
|---|---|
| Enterprise Value | $937.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.96 |
| Beta | 1.13 |
| Outstanding Shares | 47,739,816 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.99 |
|---|---|
| PEG | -12.1 |
| Price to Sales | 18.8 |
| Price to Book Ratio | -9.4 |
| Enterprise Value to Revenue | 9.95 |
| Enterprise Value to EBIT | -7.75 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | -1.4 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About UroGen Pharma Ltd
CEO: Elizabeth Barrett